Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
Provided By GlobeNewswire
Last update: Dec 16, 2024
CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Eric Shaff, President and Chief Executive Officer, will present a corporate overview on January 16, 2025 at 7:30 a.m. PT.
Read more at globenewswire.com
